Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Vortex 

Palisade Bio Inc. diskutieren

Palisade Bio Inc.

WKN: A3DZ0T / Symbol: PALI / Name: Palisade Bio / Aktie / Pharmazeutika / Small Cap /

0,34 €
-6,68 %

Sell Seneca Biopharma Inc.

Palisade Bio, Inc. (NASDAQ: PALI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating.
Ratings data for PALI provided by MarketBeat

Einschätzung Buy
Rendite (%) -37,74 %
Kursziel 1,38
Veränderung
Endet am 17.11.24

Palisade Bio, Inc. (NASDAQ: PALI) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $1.50 price target on the stock.
Ratings data for PALI provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 21,17
Veränderung
Endet am 16.04.25

Palisade Bio, Inc. (NASDAQ: PALI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $22.50 price target on the stock.
Ratings data for PALI provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 21,06
Veränderung
Endet am 01.05.25

Palisade Bio, Inc. (NASDAQ: PALI) had its "buy" rating re-affirmed by analysts at Maxim Group. They now have a $22.50 price target on the stock.
Ratings data for PALI provided by MarketBeat